Dergiler / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 6

Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation

Sayfa
967–970
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This report contributes to the literature bydefining a new mutation in HSPG2 gene and showing the importance of earlydiagnosis of the disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Schwartz Jampel syndrome was first described in 1962.
📊
Temel Bulgular & Veri:It is an autosomalrecessive disease with generalized myotonic myopathy and skeletal dysplasia.A mutation in the HSPG2 gene occurs.
💡
Sonuç & Katkı:This report contributes to the literature bydefining a new mutation in HSPG2 gene and showing the importance of earlydiagnosis of the disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Schwartz Jampel syndrome was first described in 1962. It is an autosomalrecessive disease with generalized myotonic myopathy and skeletal dysplasia.A mutation in the HSPG2 gene occurs. Approximately 150 cases have beenreported in literature. A 4-year-old girl presented to the pediatric neurologyclinic due to difficulty in walking. The patient had difficulty opening hermouth and swallowing. She was unable to eat solid foods and was bottlefed. She was able to stand leaning forward, with her legs open and with onehand supported. Bilateral blepharospasm, posterior cleft palate, microstomia,pursed lips, kyphoscoliosis, contracture in the elbows, long thin fingers andcampodactyly in the bilateral 5th fingers were present. Myotonic contractionwith thenar percussion was observed. Previously undescribed mutation wasdetermined in HSPG2 gene in the genetic study. Oral carbamazepine therapywas initiated and 1.5 months later the patient’s muscle rigidity had decreasedand her motor skills had improved. This report contributes to the literature bydefining a new mutation in HSPG2 gene and showing the importance of earlydiagnosis of the disease.

🔖

Bu Makaleye Atıf Yap

GÜRBÜZ, G., ALBAYRAK, H. M. (2019). Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 6, 967–970. https://ajindex.com/articles/412082

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Schwartz O, Jampel RS. Congenital blepharophimosis associated with a unique generalized myopathy. Arch Ophthalmol 1963; 68: 52-57
  2. Wiedemann HR, Stuve A. Stuve-Wiedemann syndrome: Update and historical footnote. Am J Med Genet 1996; 63: 12-16
  3. Giedion A, Boltshauser E, Briner J, et al. Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia. Eur J Pediatr 1997; 156: 214-223
  4. Viljoen D, Beighton P. Schwartz-Jampel syndrome (chondrodystrophic myotonia) J Med Genet 1992; 29: 58-62
  5. Ho NC, Sandusky S, Madike V, Francomano CA, Dalakas MC. Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report. BMC Neurol 2003; 3: 3
  6. Arikawa-Hirasawa E, Le AH, Nishino I, et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 2002; 70: 1368-1375
  7. Peng HB, Xie H, Rossi SG, Rotundo RL. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 1999; 145: 911-921
  8. Nicole S, Davoine CS, Topaloglu H, et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 2000; 26: 480-483
  9. Polat İ, Karaoğlu P, Yiş U, Kurul SH. Schwartz-Jampel syndrome with gastroduodenal bleeding. J Pediatr Neurosci 2016; 11: 255-257
  10. Ray S, Rubin AP. Anaesthesia in a child with SchwartzJampel syndrome. Anaesthesia 1994; 49: 600-602
  11. Topaloglu H, Serdaroglu A, Okan M, Gucuyener K, Topcu M. Improvement of myotonia with carbamazepine in three cases with the SchwartzJampel syndrome. Neuropediatrics 1993; 24: 232- 234
  12. Lucci LM, Yen MT, Anderson RL, Hwang IP, Black RE. Orbicularis myectomy with levator advancement in Schwartz-Jampel syndrome. Am J Ophthalmol 2001; 132: 799-801.